Inari Medical, Inc. (NARI)
NASDAQ: NARI · Real-Time Price · USD
50.97
-0.35 (-0.68%)
Nov 19, 2024, 4:00 PM EST - Market closed
Inari Medical Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Inari Medical stock have an average target of 59.13, with a low estimate of 47 and a high estimate of 74. The average target predicts an increase of 16.01% from the current stock price of 50.97.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inari Medical stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 2 | 2 | 2 | 2 |
| Buy | 3 | 4 | 3 | 3 | 3 | 3 |
| Hold | 2 | 3 | 3 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 30, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $46 → $50 | Hold | Maintains | $46 → $50 | -1.90% | Oct 29, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $50 → $52 | Hold | Maintains | $50 → $52 | +2.02% | Oct 29, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $71 → $74 | Strong Buy | Maintains | $71 → $74 | +45.18% | Oct 29, 2024 |
| Baird | Baird | Buy Maintains $66 → $67 | Buy | Maintains | $66 → $67 | +31.45% | Oct 29, 2024 |
Financial Forecast
Revenue This Year
615.04M
from 493.63M
Increased by 24.59%
Revenue Next Year
727.44M
from 615.04M
Increased by 18.28%
EPS This Year
-0.76
from -0.03
EPS Next Year
0.14
from -0.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 634.2M | 770.1M | 929.7M | |
| Avg | 615.0M | 727.4M | 852.2M | |
| Low | 590.1M | 685.2M | 792.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 28.5% | 25.2% | 27.8% | |
| Avg | 24.6% | 18.3% | 17.1% | |
| Low | 19.5% | 11.4% | 9.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.69 | 0.87 | 1.73 | |
| Avg | -0.76 | 0.14 | 0.53 | |
| Low | -0.95 | -1.68 | -1.89 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | 1,113.2% | |
| Avg | - | - | 268.6% | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.